Iterum Therapeutics plc (ITRM) Q2 2023 Earnings Call Transcript


Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET

Company Participants

Louise Barrett – Senior Vice President, Legal Affairs

Corey Fishman – Chief Executive Officer

Judy Matthews – Chief Financial Officer

Conference Call Participants

Thomas Yip – H.C. Wainwright

Operator

Good morning, and welcome to the Iterum Therapeutics Second Quarter 2023 Financial Results Call. My name is Carla, and I will be the operator of today’s call. [Operator Instructions]

I would now like to pass the conference over to our host, Louise Barrett to begin. Louise, please go ahead when you’re ready.

Louise Barrett

Thank you, Carla. Good morning, and welcome to Iterum Therapeutics second quarter 2023 financial results. A press release with our second quarter results was issued earlier this morning and can be find on our website. We are joined this morning by Corey Fishman, CEO; and Judy Matthews, CFO. Corey will provide some opening remarks. Judy will provide details on our financial results and then we’ll open the lines for Q&A.

Before we begin, I would like to remind you that from the information presented on this conference call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including the development therapeutic and massive potential sulopenem, the timing, conduct, progress and results of our ongoing REASSURE clinical trial, including the ability to complete planned enrollment within the projected time frame and the timing of top line results, the expected timing of resubmission of our NDA, the term and coverage provided by our patent and sufficiency of our cash resources and our valuation of corporate strategic and financing strategies and alternatives to fund future development operations.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including uncertainties inherent in



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *